Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
Summary : The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates…